Data cut off date,Web posting date,Bullets,CAEFISS AEFI term,CAEFISS Frequency,CV AEFI term,CV Frequency,AEFI term,Frequency
2021-01-01,2021-01-08,Most frequently reported AEFI (1st),Vaccination site reactions,7,Facial paralysis,1,Vaccination site reactions,7
2021-01-01,2021-01-08,Most frequently reported AEFI (2nd),Nausea,4,Headache,1,Nausea,4
2021-01-01,2021-01-08,Most frequently reported AEFI (3rd),Paraesthesia,3,Pain in extremity,1,Paraesthesia,3
2021-01-01,2021-01-08,Most frequently reported AEFI (4th),Pruritis,3,Chills,1,Pruritis,3
2021-01-01,2021-01-08,Most frequently reported AEFI (5th),Urticaria,3,Syncope,1,Urticaria,3
2021-01-01,2021-01-08,Most commonly reported serious AEFI (1st),Anaphylaxis,2,None at this time,,Anaphylaxis,2
2021-01-01,2021-01-08,Most commonly reported serious AEFI (2nd),Other allergic reactions,1,None at this time,,Other allergic reactions,1
2021-01-01,2021-01-08,Total number of AEFIs,Total,60,Total,5,Total,65
2021-01-08,2021-01-15,Most frequently reported AEFI (1st),Vaccination site reactions,9,SARS-CoV-2 positive/ COVID-19,3,Vaccination site reactions,9
2021-01-08,2021-01-15,Most frequently reported AEFI (2nd),Paraesthesia,8,Drug ineffective,3,Paraesthesia,8
2021-01-08,2021-01-15,Most frequently reported AEFI (3rd),Nausea,5,Hypersensitivity,1,Nausea,5
2021-01-08,2021-01-15,Most frequently reported AEFI (4th),Pruritis,5,Abdominal pain upper,1,Pruritis,5
2021-01-08,2021-01-15,Most frequently reported AEFI (5th),Chest discomfort,4,"Contusion, eye pain, eye swelling, injection site nodule",1 each,Chest discomfort,4
2021-01-08,2021-01-15,Most commonly reported serious AEFI (1st),Anaphylaxis,3,SARS-CoV-2 positive/ COVID-19,3,Anaphylaxis,3
2021-01-08,2021-01-15,Most commonly reported serious AEFI (2nd),None at this time ,,Drug ineffective,3,Vaccination failure,3
2021-01-08,2021-01-15,Total number of AEFIs,Total,103,Total,12,Total,115
2021-01-15,2021-01-22,Most frequently reported AEFI (1st),Vaccination site reactions,53,SARS-CoV-2 positive/ COVID-19,5,Vaccination site reactions ,53
2021-01-15,2021-01-22,Most frequently reported AEFI (2nd),Paraesthesia,26,Injection site pain,4,Paraesthesia,26
2021-01-15,2021-01-22,Most frequently reported AEFI (3rd),"Pruritis, Urticaria",12 each,Swelling,3,Pruritis|Urticaria,12 each
2021-01-15,2021-01-22,Most frequently reported AEFI (4th),"Anaphylaxis, Headache, Hypoaesthesia, Nausea",11 each,Headache,2,Anaphylaxis|Headache|Hypoaesthesia|Nausea,11 each
2021-01-15,2021-01-22,Most frequently reported AEFI (5th),"Dyspnoea, Hypoaesthesia oral",10 each,Tachycardia,1,Dyspnoea|Hypoaesthesia oral,10 each
2021-01-15,2021-01-22,Most commonly reported serious AEFI (1st),Anaphylaxis,10,SARS-CoV-2 positive/ COVID-19,5,Anaphylaxis,10
2021-01-15,2021-01-22,Most commonly reported serious AEFI (2nd),Panic attack,1,Injection site pain,4,SARS-CoV-2 positive/ COVID-19,6
2021-01-15,2021-01-22,Total number of AEFIs,Total ,364,Total ,,Total,
2021-01-22,2021-01-29,Most frequently reported AEFI (1st),Vaccination site reactions,209,SARS-CoV-2 positive/ COVID-19,7,Vaccination site reactions,209
2021-01-22,2021-01-29,Most frequently reported AEFI (2nd),Paraesthesia,49,Headache,7,Paraesthesia,49
2021-01-22,2021-01-29,Most frequently reported AEFI (3rd),Pruritus,36,Swelling,4,Pruritus,36
2021-01-22,2021-01-29,Most frequently reported AEFI (4th),Urticaria,35,Vomiting,3,Urticaria,35
2021-01-22,2021-01-29,Most frequently reported AEFI (5th),Headache,28,Paraesthesia oral,2,Headache,28
2021-01-22,2021-01-29,Most commonly reported serious AEFI (1st),Anaphylaxis,23,SARS-CoV-2 positive/ COVID-19,7,Anaphylaxis,23
2021-01-22,2021-01-29,Most commonly reported serious AEFI (2nd),"Bell's Palsy, Cardiac arrhythmias, Cerebrovascular accident, Death, Myelitis",1 each,Headache,7,,
2021-01-22,2021-01-29,Total number of AEFIs,Total ,"1,009",Total ,,Total,